These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24615887)

  • 21. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of selective PPARγ modulators in the differentiation of osteoclasts.
    Wu H; Li L; Ma Y; Chen Y; Zhao J; Lu Y; Shen P
    J Cell Biochem; 2013 Sep; 114(9):1969-77. PubMed ID: 23494891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothermia inhibits osteoblast differentiation and bone formation but stimulates osteoclastogenesis.
    Patel JJ; Utting JC; Key ML; Orriss IR; Taylor SE; Whatling P; Arnett TR
    Exp Cell Res; 2012 Oct; 318(17):2237-44. PubMed ID: 22771842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPAR-gamma regulates osteoclastogenesis in mice.
    Wan Y; Chong LW; Evans RM
    Nat Med; 2007 Dec; 13(12):1496-503. PubMed ID: 18059282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations.
    Hasegawa T; Oizumi K; Yoshiko Y; Tanne K; Maeda N; Aubin JE
    BMC Dev Biol; 2008 Jul; 8():71. PubMed ID: 18625072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: a pilot study.
    Bak EJ; Park HG; Kim M; Kim SW; Kim S; Choi SH; Cha JH; Yoo YJ
    J Periodontol; 2010 Mar; 81(3):412-9. PubMed ID: 20192868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
    Samadfam R; Awori M; Bénardeau A; Bauss F; Sebokova E; Wright M; Smith SY
    J Endocrinol; 2012 Feb; 212(2):179-86. PubMed ID: 22062085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.
    Molinuevo MS; Schurman L; McCarthy AD; Cortizo AM; Tolosa MJ; Gangoiti MV; Arnol V; Sedlinsky C
    J Bone Miner Res; 2010 Feb; 25(2):211-21. PubMed ID: 19594306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
    Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptors gamma and alpha agonists stimulate cardiac glucose uptake via activation of AMP-activated protein kinase.
    Xiao X; Su G; Brown SN; Chen L; Ren J; Zhao P
    J Nutr Biochem; 2010 Jul; 21(7):621-6. PubMed ID: 19570670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenofibrate induces PPARα and BMP2 expression to stimulate osteoblast differentiation.
    Kim YH; Jang WG; Oh SH; Kim JW; Lee MN; Song JH; Yang JW; Zang Y; Koh JT
    Biochem Biophys Res Commun; 2019 Dec; 520(2):459-465. PubMed ID: 31607484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells.
    Gao Y; Xue J; Li X; Jia Y; Hu J
    J Pharm Pharmacol; 2008 Dec; 60(12):1695-700. PubMed ID: 19000376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo.
    Still K; Grabowski P; Mackie I; Perry M; Bishop N
    Calcif Tissue Int; 2008 Oct; 83(4):285-92. PubMed ID: 18836674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
    Hennuyer N; Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1897-902. PubMed ID: 15994444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible beneficial effect of peroxisome proliferator-activated receptor (PPAR)--α and γ agonist against a rat model of oral dyskinesia.
    Grover S; Kumar P; Singh K; Vikram V; Budhiraja RD
    Pharmacol Biochem Behav; 2013 Oct; 111():17-23. PubMed ID: 23948071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
    Liang F; Wang F; Zhang S; Gardner DG
    Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining the safety of PPAR agonists - current trends and future prospects.
    Bortolini M; Wright MB; Bopst M; Balas B
    Expert Opin Drug Saf; 2013 Jan; 12(1):65-79. PubMed ID: 23134541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
    Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
    J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.